N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester

Create: 12/30/2016

Expired Date:	03/31/2017
Category:	Health&Medical&Pharmaceutical
Message:	Orlistat is used for the treatment of obesity. The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% and 24.8% achieved at least a 10% decrease in body fat. After orlistat was stopped, a significant number of subjects regained weight-up to 35% of the weight they had lost. The incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%).Long-term use of orlistat also leads to a modest reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood pressure respectively).





City:	Wuhan Hubei[CN]
Location:

Jan 19 2017	Cialis(CAS NO: 171596-29-5)	414
Jan 19 2017	(CAS NO.:131543-23-2) Sex Enhancement Powder Sildenafil Mesylate	424
Jan 19 2017	Sildenafil(CAS:139755-83-2)	391
Jan 19 2017	17beta-Hydroxy-1alpha-methyl-5alpha-androstan-3-one	406
Jan 19 2017	Mesterolone(proviron)	413
Jan 19 2017	Teslac	416
Jan 19 2017	6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-methanone hydrochloride	444
Jan 19 2017	Toremifene citrate	396
Jan 19 2017	TURINABOL,kessar	397
Jan 19 2017	Toremifene Citrate	415